Theoretical Modeling of Coagulation Management with Therapeutic Plasma or Prothrombin Complex Concentrate

Herbert Schöchl, Oliver Grottke, Ken Sutor, Kieron Dony, Martin Schreiber, Marco Ranucci, Peter W. Collins

    Research output: Contribution to journalArticle

    3 Citations (Scopus)

    Abstract

    Prothrombin complex concentrates (PCCs) have been associated with a possible risk of thromboembolic complications, potentially attributable to an increased ratio of the plasma concentration of factor II (FII) to antithrombin (AT). We developed a mathematical model to examine the relationship between amounts of PCC or therapeutic plasma administered, and plasma levels of FII and AT. The model showed that PCC produces substantial increases in plasma levels of FII but only small changes in AT, increasing the FII:AT ratio. Therapeutic plasma was shown to have only modest effects on levels of FII or AT, unless high doses are used.

    Original languageEnglish (US)
    Pages (from-to)1471-1474
    Number of pages4
    JournalAnesthesia and Analgesia
    Volume125
    Issue number5
    DOIs
    StatePublished - Nov 1 2017

    Fingerprint

    Antithrombins
    Therapeutics
    Theoretical Models
    prothrombin complex concentrates

    ASJC Scopus subject areas

    • Anesthesiology and Pain Medicine

    Cite this

    Theoretical Modeling of Coagulation Management with Therapeutic Plasma or Prothrombin Complex Concentrate. / Schöchl, Herbert; Grottke, Oliver; Sutor, Ken; Dony, Kieron; Schreiber, Martin; Ranucci, Marco; Collins, Peter W.

    In: Anesthesia and Analgesia, Vol. 125, No. 5, 01.11.2017, p. 1471-1474.

    Research output: Contribution to journalArticle

    Schöchl, Herbert ; Grottke, Oliver ; Sutor, Ken ; Dony, Kieron ; Schreiber, Martin ; Ranucci, Marco ; Collins, Peter W. / Theoretical Modeling of Coagulation Management with Therapeutic Plasma or Prothrombin Complex Concentrate. In: Anesthesia and Analgesia. 2017 ; Vol. 125, No. 5. pp. 1471-1474.
    @article{14400cbd9dfd4b278c1f7b61d65712a7,
    title = "Theoretical Modeling of Coagulation Management with Therapeutic Plasma or Prothrombin Complex Concentrate",
    abstract = "Prothrombin complex concentrates (PCCs) have been associated with a possible risk of thromboembolic complications, potentially attributable to an increased ratio of the plasma concentration of factor II (FII) to antithrombin (AT). We developed a mathematical model to examine the relationship between amounts of PCC or therapeutic plasma administered, and plasma levels of FII and AT. The model showed that PCC produces substantial increases in plasma levels of FII but only small changes in AT, increasing the FII:AT ratio. Therapeutic plasma was shown to have only modest effects on levels of FII or AT, unless high doses are used.",
    author = "Herbert Sch{\"o}chl and Oliver Grottke and Ken Sutor and Kieron Dony and Martin Schreiber and Marco Ranucci and Collins, {Peter W.}",
    year = "2017",
    month = "11",
    day = "1",
    doi = "10.1213/ANE.0000000000002410",
    language = "English (US)",
    volume = "125",
    pages = "1471--1474",
    journal = "Anesthesia and Analgesia",
    issn = "0003-2999",
    publisher = "Lippincott Williams and Wilkins",
    number = "5",

    }

    TY - JOUR

    T1 - Theoretical Modeling of Coagulation Management with Therapeutic Plasma or Prothrombin Complex Concentrate

    AU - Schöchl, Herbert

    AU - Grottke, Oliver

    AU - Sutor, Ken

    AU - Dony, Kieron

    AU - Schreiber, Martin

    AU - Ranucci, Marco

    AU - Collins, Peter W.

    PY - 2017/11/1

    Y1 - 2017/11/1

    N2 - Prothrombin complex concentrates (PCCs) have been associated with a possible risk of thromboembolic complications, potentially attributable to an increased ratio of the plasma concentration of factor II (FII) to antithrombin (AT). We developed a mathematical model to examine the relationship between amounts of PCC or therapeutic plasma administered, and plasma levels of FII and AT. The model showed that PCC produces substantial increases in plasma levels of FII but only small changes in AT, increasing the FII:AT ratio. Therapeutic plasma was shown to have only modest effects on levels of FII or AT, unless high doses are used.

    AB - Prothrombin complex concentrates (PCCs) have been associated with a possible risk of thromboembolic complications, potentially attributable to an increased ratio of the plasma concentration of factor II (FII) to antithrombin (AT). We developed a mathematical model to examine the relationship between amounts of PCC or therapeutic plasma administered, and plasma levels of FII and AT. The model showed that PCC produces substantial increases in plasma levels of FII but only small changes in AT, increasing the FII:AT ratio. Therapeutic plasma was shown to have only modest effects on levels of FII or AT, unless high doses are used.

    UR - http://www.scopus.com/inward/record.url?scp=85032436246&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85032436246&partnerID=8YFLogxK

    U2 - 10.1213/ANE.0000000000002410

    DO - 10.1213/ANE.0000000000002410

    M3 - Article

    C2 - 28857856

    AN - SCOPUS:85032436246

    VL - 125

    SP - 1471

    EP - 1474

    JO - Anesthesia and Analgesia

    JF - Anesthesia and Analgesia

    SN - 0003-2999

    IS - 5

    ER -